Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance

BACKGROUND: Incretin-based therapies are rapidly becoming one of the main glycemic control strategies in diabetes. Considering the large numbers of papillary thyroid carcinomas (PTCs) and possible effects of glucagon-like peptide-1 (GLP-1) on cell proliferation, the expression of GLP-1 receptor (GLP...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Min Jung, Kwon, Su Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285044/
https://www.ncbi.nlm.nih.gov/pubmed/25559577
http://dx.doi.org/10.3803/EnM.2014.29.4.536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285044/
https://www.ncbi.nlm.nih.gov/pubmed/25559577
http://dx.doi.org/10.3803/EnM.2014.29.4.536

Ejemplares similares